期刊文献+

SHB基因的突变与乳腺癌的关系 被引量:1

Ralationship between Mutation of SHB Gene and Breast Cancer
下载PDF
导出
摘要 目的通过对乳腺癌组织和健康人外周血中SHB(Src homology2 domain containing adaptor protein B,SHB)基因的单核苷酸多态(single nucleotide polymorphism SNP)进行检测,研究SHB基因与乳腺癌的相关性。方法对SHB基因的启动子、外显子以及临近的内含子区域,使用PCR扩增和DNA测序方法,分别在96例乳腺癌患者的肿瘤组织及96例健康人的外周血进行测序,比较它们之间可能存在的差异,确定该基因是否与乳腺癌相关。结果本研究发现SHB基因共有7个SNP,其中5个是高频SNP,2个是低频SNP,该基因的启动子区一个SNP在健康人和乳腺癌患者之间差异有统计学意义(P<0.05)。结论 SHB基因的启动子的SNP可能与乳腺癌的发生有关。 Objective To study the association of Src homology 2 domain containing adaptor protein B(SHB)gene with pathogenesis of breast cancer,the single nucleotide polymorphism(SNP)of gene SHB in turnor tissue and henlthy peripheral blood were detected.Methods The tissues of 96 patients with breast cancer were included in a case-control associative study,and the circulating DNA of 96 healthy people were measured at the same time.Sequences of proximal promoter,coding regions(including sequence near splicing site) of SHB gene were detected by PCR amplification and DNA-sequencing.Results A total of 7SNPs were identified for SHB gene;there were 5 high frequency SNPs and 2 low frequency SNPs.One SNP(P/-1047) located in the promoter of SHB had significant difference of allele and genotype between breast cancer and controls(P〈0.05).Conclusion The SNP in the promoter of SHB gene might be related to the occurrence of breast cancer.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第11期1261-1263,共3页 Cancer Research on Prevention and Treatment
关键词 乳腺癌 基因 单核苷酸多态 突变 Breast cancer Gene Single Nucleotide Ploymorphism Mutations
  • 相关文献

参考文献9

  • 1张海添,陆云飞,曾健,廖清华,林坚.乳腺癌BRCA1基因突变的筛查研究[J].肿瘤防治研究,2005,32(9):533-535. 被引量:3
  • 2赖春宁 王建安 黎燕 等.38例散发乳腺癌患者BRCAl基因突变检测.中国肿瘤生物治疗杂志,1999,6(3):168-170.
  • 3Zhou X, Coad J, Ducatman B, et al. SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast,implying its involvement in breast oncogenesis[J].His topathology, 2(}08,53 (4) = 389-402.
  • 4Maretzky T, Le Gall SM, Worper/berg-Pietruk S, et al. Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer [J]. Cancer Res, 2009,69 ( 11 ) : 4573-4576.
  • 5Yaoi T, Chamnonqpol S, Jiang X, et al. Src homology 2 domainbased high throughput assays for profiling downstream mole cules in receptor tyrosine kinase pathways[J]. Mol Cell Proteomics, 2006,5 (5):959-968.
  • 6Chen CH,Chen MK,Jenq KC, et al. Effects of peptidic antagonists of Grb2-SH2 on human breast cancer cells[J]. Protein Pept Lett,2010,17(1) :44-53.
  • 7Hawthorne VS, Huang WC, Neal CI., et al. ErbB2-mediated Src and signal transducer and activator of transcription 3 acti vation leads to transcriptional up-regulation of p21Cip/ and chemoresistance in breast cancer cells [J]. Mol Cancer Res, 2009,7 (4) : 592-600.
  • 8Zhang Y,Zhou S,Wavreille AS,et al. Cyclic peptidyl inhibitors of Grb2 and tensin SH2 domains identified from combinatorial libraries[J].J Comb Chem,2008,10(2) :247-255.
  • 9Ju H, Lim B, Kim M, et al. A regulatory polymorphism at position-309 in PTPRCAP is associated with susceptibility to dif fuse-type gastric cancer and gene expression[J]. Neoplasia 2009,11 (12) : 1340- 1347.

二级参考文献11

共引文献2

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部